Viewing nowRosuton 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Huons Co., Ltd.

MFDS item code 201400385 · Approved 2014.01.28 · Insurance code 670606780
Improvement of dyslipidemia, reduction of cardiovascular disease risk, inhibition of atherosclerosis progression
This medication is primarily used as an adjunct therapy when diet and exercise alone do not control primary hypercholesterolemia and mixed dyslipidemia, effectively lowering total cholesterol and LDL-cholesterol levels to slow the progression of atherosclerosis. It also helps in the treatment of patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. In specific pediatric patients aged 10 to 17 years, it can be used in conjunction with diet to reduce cholesterol levels. Additionally, it contributes to reducing the risks of stroke, myocardial infarction, and arterial revascularization procedures in adults at high cardiovascular risk. In summary, this medication is effectively used for the prevention of hypercholesterolemia and cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 mg per day. 3. Elderly patients: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower; an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 6. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals allergic to this drug or those with liver disease, muscle disorders, severely impaired kidney function, pregnant or lactating women, and those taking certain drugs should not take this medication. Moreover, it is important to periodically monitor liver function and muscle condition while taking this medication. If there are signs of liver function deterioration or symptoms like muscle pain or weakness, consult a doctor immediately. This medication should be administered cautiously in individuals who consume large amounts of alcohol or have a history of liver disease, and treatments of any underlying conditions should be prioritized in cases of hypothyroidism or nephrotic syndrome. Rarely, muscle-related side effects may occur, so it is essential to inform healthcare personnel of any symptoms such as muscle pain, weakness, or cramps. Special caution is necessary for the elderly or those with impaired kidney function. This medication contains lactose, so individuals with lactose intolerance should not take it, and caution is also necessary for those with certain genetic muscle disorders or alcoholism. Women of childbearing potential should use appropriate contraception while taking this medication and must stop immediately if they become pregnant. Lactating women should also avoid using this medication. When combining this drug with others, potential interactions may occur, so patients must inform their doctor or pharmacist of any current medications. Caution is especially warranted when taking it with certain antivirals, immunosuppressants, antifungals, antibiotics, or fibrates. In case of overdose, as there is no specific antidote, treatment should be symptomatic, and monitoring of liver function and muscle enzyme levels is necessary. This medication is known to have little impact on the ability to drive or operate machinery, but rare instances of dizziness may occur, so caution is advised. Lastly, if severe skin reactions, significant liver damage, or symptoms of muscle disease occur while taking this medication, discontinue it immediately and consult healthcare personnel.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, ALT increase, chest pain, muscle cramps, gout, erectile dysfunction, AST increase, numbness, paraesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. Additionally, avoid storing it in excessively hot or cold places, and it is best kept at room temperature between 1 and 30 degrees Celsius.
Yellow round film-coated tablets
28 tablets (14 tablets/Alu-Alu x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Huons Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.